Chengda Bio Announces RMB 400 Million Investment to Co-Establish Biopharmaceutical Industry Investment Fund

Nandu Zhixun, January 26thCDBIOAnnouncement: The company plans to contribute 400 million yuan as a limited partner, together with the controlling shareholder.Liaoning Cheng Da Co.,Ltd.Co., Ltd. (with a capital contribution of 10,000.00 million yuan), wholly-owned subsidiary ShenzhenCDBIOInvestment Co., Ltd. (contributing RMB 100.00 million) and Chengda Coastal Industry (Dalian) Fund Management Co., Ltd. (contributing RMB 100.00 million) jointly initiated the establishment.CDBIOPharmaceutical Industry Investment Fund, with the first phase of the fund's subscribed size at 502,000,000 yuan, and a total scale not exceeding 1,000,000,000 yuan; meanwhile, the company's wholly-owned subsidiary, Shenzhen CDBIO Investment Co., Ltd., andLiaoning Cheng Da Co.,Ltd.Wholly-owned subsidiaryLiaoning Cheng Da Co.,Ltd.Medical ServicesManagement Co., Ltd. plans to contribute a total of 50 million yuan to increase the capital of Beijing Gene Key Life Technology Co., Ltd., of which CDBIO will contribute 40 million yuan and Chengda Medical will contribute 10 million yuan.

(Source: Southern Finance Network)